Back

Predictive value of postoperative N-terminal pro-B-type natriuretic peptide in patients suffering myocardial injury after noncardiac surgery

28 August 2026 (09:05 - 09:15)
Organised by: Logo
Congress Presentation Part of: Smarter perioperative cardiovascular risk assessment: biomarkers, atrial fibrillation, and digital tools Noncardiac Surgery / Presurgical Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Flavia Borges

McMaster University, Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail
Manual versus natural language processing versus large language model screening for preoperative identification of cardiovascular diseases: a prospective cohort study
Doctor K. Durak (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Prognostic role of a preoperative troponin elevation in patients undergoing urgent or emergency noncardiac surgery: a pooled analysis
Doctor S. Maiorano (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Cardiovascular outcomes of wearable device-detected atrial fibrillation after major non-cardiac surgery: a prospective cohort study
Doctor K. Durak (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Preoperative B-type natriuretic peptide independently predicts perioperative cardiac complications in vascular surgery: a systematic review and meta-analysis
Mr G. Imperatore (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Validation of ESC criteria for perioperative myocardial infarction/injury with the new 6th generation high sensitivity cardiac troponin T assay
Doctor K. Durak (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Smarter perioperative cardiovascular risk assessment: biomarkers, atrial fibrillation, and digital tools
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 09:05 CET
You may be interested in
thumbnail
Congress Session
Risk prediction in non-cardiac surgery
1 September 2025
thumbnail
Congress Presentation
Utility of NT-proBNP for detecting heart failure and assessing prognosis in elderly myocardial infarction survivors: insights from the OMEMI trial
9 May 2026
thumbnail
Congress Presentation
Empagliflozin to prevent post-operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (EMPOAF), a randomized, double-blind, placebo-controlled trial
28 August 2026
thumbnail
Congress Presentation
Association of preoperative NT-proBNP with 30-day and five-year mortality after cardiac surgery
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources